NCT04232709

Brief Summary

The objective of the current project is to pilot the evaluation of the health and economic benefits of having online access to health information in the context of providing telemedicine support for oncology patients receiving outpatient systemic therapy in Ontario. This pilot study will determine the feasibility of conducting a full-scale randomized controlled trial that could definitively determine whether the addition of access to patients' health information in the after-hours telemedicine program reduces emergency department use, affect patients' experience of care, or improve patient-reported health. The study will be conducted at, and with patients from, the Stronach Regional Cancer Centre (SRCC) at Southlake. Eligible patients will be adults (at least 18 years of age) with a confirmed cancer diagnosis, and initiating or continuing treatment with systemic therapy at the SRCC. Prospective patients will be randomized across two arms. Recruitment will take place during a 6.5-month recruitment period and followed up for a period of 3 months.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P50-P75 for not_applicable cancer

Timeline
Completed

Started Feb 2018

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2018

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

March 4, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 9, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 9, 2019

Completed
8 months until next milestone

First Posted

Study publicly available on registry

January 18, 2020

Completed
Last Updated

January 18, 2020

Status Verified

January 1, 2020

Enrollment Period

1.3 years

First QC Date

March 4, 2019

Last Update Submit

January 14, 2020

Conditions

Keywords

systemic therapychemotherapytargeted therapyimmunotherapyafter-hours telemedicineshared electronic patient recordsymptom managementoncology

Outcome Measures

Primary Outcomes (7)

  • Proportion of patients willing to be randomized

    The proportion of patients willing to be randomized

    9.5 Months

  • Proportion of enrolled patients lost to follow up

    The proportion of enrolled patients lost to follow up in each randomized group

    9.5 Months

  • Number of attempted questionnaires relative to number of questionnaires that should have been completed

    The number of completed questionnaires for both patient participants and healthcare provider participants in relation to the total number of times a questionnaire should have been completed

    9.5 Months

  • Number of completed questionnaires relative to number of questionnaires that should have been completed

    The number of attempted questionnaires for both patient participants and healthcare provider participants in relation to the total number of times a questionnaire should have been completed

    9.5 Months

  • Percent of total emergency department (ED) visits reported that occurred at Southlake

    Comparison of total self-reported ED visits to total ED visits recorded in institutional records

    9.5 Months

  • Time to complete questionnaire battery

    Estimation of time required for patients to complete the questionnaires at each timepoint

    9.5 Months

  • Completion rate for satisfaction survey

    Percent of callers for whom Bayshore's satisfaction survey results were obtained

    9.5 Months

Secondary Outcomes (13)

  • Self-reported health service utilization

    3 Months

  • Hospital-reported health service utilization: Emergency Department Visits

    3 Months

  • Hospital-reported health service utilization: Outcomes of ED Visits

    3 Months

  • Hospital-reported health service utilization: Length of Hospital Stay

    3 Months

  • Edmonton Symptom Assessment System-revised (ESAS-r) Scale

    3 Months

  • +8 more secondary outcomes

Study Arms (2)

After-hours care

NO INTERVENTION

Patients in the after-hours care (AH) group will receive the usual (telemedicine) care. That is, they will have the option to call the after-hours centre and receive help from the oncology nurses using the COSTaRS practice guides to manage their after-hours symptoms.

After-hours care w/personal health info

EXPERIMENTAL

Patients in the after-hours care with personal health information (AH-PHI) group will also receive the usual (telemedicine) care. However, if they call the telemedicine service, the oncology nurses will have access to some of their personal health information from the cancer centre (i.e., a shared electronic patient record) via the MedChart platform.

Other: Shared electronic patient record

Interventions

MedChart allows access to a shared electronic patient record that contains selected information related to a patient's cancer treatment. If a patient contacts the after-hours telemedicine service, the oncology nurse will have access to this shared record

Also known as: MedChart
After-hours care w/personal health info

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Confirmed cancer diagnosis (all cancers, all stages)
  • Initiating or continuing treatment with systemic therapy (oral or injected/IV; excluding hormonal therapy for breast or prostate cancer) at Stronach Regional Cancer Centre at Southlake

You may not qualify if:

  • Being treated with radiation
  • Unable to read or understand spoken English (Required for completing the questionnaires)
  • Unable to utilize the after-hours services due to cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Southlake Regional Health Centre

Newmarket, Ontario, L3Y 2P9, Canada

Location

Related Publications (7)

  • Barbera L, Atzema C, Sutradhar R, Seow H, Howell D, Husain A, Sussman J, Earle C, Liu Y, Dudgeon D. Do patient-reported symptoms predict emergency department visits in cancer patients? A population-based analysis. Ann Emerg Med. 2013 Apr;61(4):427-437.e5. doi: 10.1016/j.annemergmed.2012.10.010. Epub 2013 Jan 4.

    PMID: 23290526BACKGROUND
  • Cancer Care Ontario. (2014). Quality Person-Centred Systemic Treatment in Ontario, 2014-2019 (pp. 1-46). Toronto, ON: Cancer Care Ontario.

    BACKGROUND
  • Cancer Quality Council of Ontario. (2016, October). Cancer Safety Quality Index: Unplanned Hospital Visits During Chemotherapy. Retrieved March 23, 2018, from http://www.csqi.on.ca/by_patient_journey/treatment/unplanned_hospital_visits_during_chemotherapy/

    BACKGROUND
  • Ferrer-Roca O, Subirana R. A four-year study of telephone support for oncology patients using a non-supervised call centre. J Telemed Telecare. 2002;8(6):331-6. doi: 10.1258/135763302320939211.

    PMID: 12537920BACKGROUND
  • Kurtz ME, Kurtz JC, Given CW, Given B. Effects of a symptom control intervention on utilization of health care services among cancer patients. Med Sci Monit. 2006 Jul;12(7):CR319-24. Epub 2006 Jun 28.

    PMID: 16810138BACKGROUND
  • Palumbo MO, Kavan P, Miller WH Jr, Panasci L, Assouline S, Johnson N, Cohen V, Patenaude F, Pollak M, Jagoe RT, Batist G. Systemic cancer therapy: achievements and challenges that lie ahead. Front Pharmacol. 2013 May 7;4:57. doi: 10.3389/fphar.2013.00057. eCollection 2013.

    PMID: 23675348BACKGROUND
  • Panattoni, L., Fedorenko, C. R., Kreizenbeck, K. L., Greenlee, S., Walker, J. R., Greenwood-Hickman, M. A., et al. (2017). Costs of potentially preventable emergency department use during cancer treatment: A regional study [Abstract]. Journal of Clinical Oncology / 2017 ASCO Annual Meeting, 35(8_suppl), Abst 6505. http://doi.org/10.1200/JCO.2017.35.8_suppl.2

    BACKGROUND

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Sacha Bhatia, MD, FRCPC, MBA

    Women's College Hospital

    PRINCIPAL INVESTIGATOR
  • Peter Anglin, MD, FRCPC, MBA

    Southlake Regional Health Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 4, 2019

First Posted

January 18, 2020

Study Start

February 1, 2018

Primary Completion

May 9, 2019

Study Completion

May 9, 2019

Last Updated

January 18, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Locations